Royality Med's technology is a powerful high-throughput organoid-like platform which mimics the development of the human brain, at high-speed. We have unprecedented ability to identify and quantify differences between diseased and healthy cells, which we call neuroloids; and with our machine-learning algorithm, we are able to see which compounds have reversed diseased cells back to health, thus predicting the therapeutic effect a drug could have on a human’s diseased brain tissues.